AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Emicizumab in Zambia
4 products registered with ZAMRA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Hemlibra 105 mg/0,7 mL Solution for Injection | ZAMRA-HM-23-25 | Roche Products | active | 21 May 2028 |
| Hemlibra 30mg/ml Solution for injection | ZAMRA-HM-23-15 | Roche Products | active | 21 May 2028 |
| Hemlibra 60 mg/0,4 mL Solution for injection | ZAMRA-HM-23-17 | Roche Products | active | 21 May 2028 |
| Hemlibra 150 mg/1 mL Solution for injection | ZAMRA-HM-23-35 | Roche Products | active | 21 May 2028 |
Emicizumab — ZAMRA Registration Details
ZAMRA (Zambia) has 4 registered products containing Emicizumab, of which 4 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Emicizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.